EIR Teva Parenteral Manufacturing Mar 2003

Caryn Mcnab FDA$595.00 - Available Now

FDA investigators audited the Teva Parenteral Manufacturing - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 14 Mar 2003.

Product details

  • Category:
  • Inspection end: 14 Mar 2003
  • Location: Irvine, United States
  • FEI: 2027158
Add To Cart